Change of use of proceeds from the h share global offering
Filed with HKEX · Stock code 2506 · · 4 pages · English
Summary by 6ix AI
Xunfei Healthcare Technology Co., Ltd. has announced a change in the use of proceeds from its H Share global offering, reallocating funds to enhance research and development efforts instead of acquisitions. The company originally planned to use a portion of the proceeds for acquiring companies but has decided that this is not the best option at this stage due to market conditions and operational needs. The Board believes this adjustment will improve the efficiency of fund utilization and support the company's overall development strategy. Shareholder approval will be sought for this change at an upcoming general meeting, with further details to be provided in a circular.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
Xunfei Healthcare Technology Co., Ltd. on 6ix
Earlier from Xunfei Healthcare Technology
- Connected transactions further deemed disposal of a subsidiary
- Continuing connected transactions with iFlytek; and continuing connected transactions with Xunfei Imaging Union
- Voluntary announcement xunfei Spark Medical Model V3.7
- Voluntary announcement entering into cooperation framework agreement with rici health
- Monthly Return of Equity Issuers on Movements in Securities for the month ended 30 September 2026
Later from Xunfei Healthcare Technology
- Inside information announcement proposed implementation of the h share full circulation by the company
- Monthly Return of Equity Issuers on Movements in Securities for the month ended 31 October 2026
- Supplemental announcement connected transaction further deemed disposal of a subsidiary
Follow Xunfei Healthcare Technology into a list and get an email when it puts out news.
Follow Xunfei Healthcare Technology